Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Abduction suspect found
Expecting 1st child together
Two children drown in pool
Shoplifter sets clerk on fire?
Honored w/ postage stamp
WA raises minimum wage
Illinois migrant crisis
Violated False Claims Act
Bear attacks 73-year-old
Philly: Alleged shooter killed
Govt. sues Union Pacific
Settles assault lawsuit
Leaves with concussion
Targets $9.2B valuation
US fines Stanford $2M
Five-year, $146M extension
14-year-old fatally shoots 3?
Open to bless gay couples?
DNC diversity goals
29 soldiers killed in Niger
Gets trailer, premiere date
Angels split with Nevin
OKs 2nd malaria vaccine
2 soldiers killed, dozen hurt
First-ever space debris fine
Panda diplomacy
Faces dog fighting charges
Jackpot rises to $1.2B
Customers regain upper hand
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
251,000 results
1d
New tests of a recently approved RSV vaccine show potent antibody response to current and past variants
New tests of a recently approved vaccine for respiratory syncytial virus—RSV—show the shot remains effective against a range ...
CBS News19d
First-ever RSV vaccine becomes available
NORTH TEXAS (CBSNewsTexas.com) – For the first time ever, an RSV vaccine has become available to those at high-risk. This comes as cases of the respiratory illness are rising in Texas and across ...
EURACTIV
11d
EU countries should prepare for seasonal respiratory diseases – health agencies
The European Medicines Agency (EMA) and the European Centre for Disease Control (ECDC) recommend targeting people at risk in ...
EuropaWire7d
GSK’s Arexvy RSV Vaccine Approved in Japan for Adults Aged 60 and Above, a First for the Country
GSK plc has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its Arexvy (respiratory ...
Pharmaceutical Technology on MSN
7d
GSK receives Japanese approval of RSV vaccine for older patients
GSK has received approval from Japan’s MHLW for RSV vaccine Arexvy to prevent RSV disease in adults aged over 60 years ...
Buffalo News19d
FDA approves RSV vaccine for moms-to-be to guard their newborns
WASHINGTON (AP) — U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with protection against the scary respiratory infection. RSV is ...
pharmaphorum
8d
CDC backs maternal use of Pfizer’s RSV vaccine
The way has been largely cleared for the rollout of Pfizer’s respiratory syncytial virus (RSV) vaccine to help protect ...
Billings Gazette
3d
What to know as fall vaccinations against COVID, flu and RSV get underway
For the first time, the U.S. has vaccines to fight a trio of viruses that cause fall and winter misery. But health officials ...
8d
GSK's RSV vaccine gets approval in Japan
GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare ...
WAMC10d
CDC recommends RSV vaccine in late pregnancy to protect newborns
In a nearly unanimous vote, advisors to the Centers for Disease Control and Prevention have recommended a new vaccine to ...
10d
RSV vaccine recommended during pregnancy as a second option to protect newborns
U.S. health officials are recommending RSV vaccinations for moms-to-be as a second option to protect newborns. The Centers ...
PMLiVE
6d
Pfizer’s Abrysvo RSV vaccine recommended by US CDC for infants
Pfizer’s respiratory syncytial virus (RSV) vaccine, Abrysvo, that can help to protect infants through the active immunisation of pregnant women, has been backed by the US Centers for Disease Control ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Get the Bing App
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices